ANTIDIABETICS AND AZOLES - VORICONAZOLE

The manufacturers of voriconazole predict that it may raise the levels of the sulphonylureas, and hypoglycaemia may result.
Until more is known careful monitoring of blood glucose is advisable during concurrent use.